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Abstract
Exome sequencing is becoming a standard tool for mapping Mendelian disease-causing (or pathogenic) non-synonymous
single nucleotide variants (nsSNVs). Minor allele frequency (MAF) filtering approach and functional prediction methods are
commonly used to identify candidate pathogenic mutations in these studies. Combining multiple functional prediction
methods may increase accuracy in prediction. Here, we propose to use a logit model to combine multiple prediction
methods and compute an unbiased probability of a rare variant being pathogenic. Also, for the first time we assess the
predictive power of seven prediction methods (including SIFT, PolyPhen2, CONDEL, and logit) in predicting pathogenic
nsSNVs from other rare variants, which reflects the situation after MAF filtering is done in exome-sequencing studies. We
found that a logit model combining all or some original prediction methods outperforms other methods examined, but is
unable to discriminate between autosomal dominant and autosomal recessive disease mutations. Finally, based on the
predictions of the logit model, we estimate that an individual has around 5% of rare nsSNVs that are pathogenic and carries
,22 pathogenic derived alleles at least, which if made homozygous by consanguineous marriages may lead to recessive
diseases.
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Introduction
Since the first successful application of exome sequencing in
finding the causal mutation for a Mendelian disease [1], many
such studies have been conducted to identify other Mendelian
disease-causing (or pathogenic) variants. Compared to genetic
linkage studies of Mendelian diseases, exome sequencing requires
a smaller number of affected individuals, who may even be
unrelated. With decreasing sequencing costs, exome sequencing is
becoming a standard tool for mapping causal genes for human
Mendelian diseases.
The most common cause of Mendelian disease is a non-
synonymous single-nucleotide variant (nsSNV) that results in a
single amino acid change in the encoded protein [2]. With the
large number (typically around 8,000–10,000) of nsSNVs in an
individual genome and the small number of (usually affected and
unrelated) individuals available, standard methods for genetic
linkage and association do not work for exome sequencing studies
of Mendelian diseases. In order to narrow down the list of
candidate nsSNVs, most exome sequencing studies rely on a hard-
filtering approach, in which the causal mutation is assumed to be
rare (with minor allele frequency (MAF) #1%) and so polymor-
phisms (with MAF.1%) found in public databases (e.g., dbSNP
and 1000 Genomes Project) as well as in-house control datasets are
discarded [3]. Moreover, variants are rejected if they are not found
in multiple cases or if they conflicts with the known disease
inheritance mode. This approach has successfully reduced the
number of mutations to look at in numerous studies, and several
tools [3–5] are therefore developed to automate this process.
However, hard-filtering in exome sequencing of Mendelian
diseases still leaves a large number (typically ,100 to 1,000) of
candidate nsSNVs. A method must, therefore, be used to predict
which of the remaining ones have serious functional consequences
and prioritize them for validation. For a comprehensive review of
these methods, see Ng and Henikoff [6]. These different methods
have their complementary strengths and combining multiple
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methods has been suggested to increase prediction accuracy [3,6].
Recently a combined predictive model (known as CONDEL [7])
has been developed. CONDEL is based on a Weighted Average of
the normalized Scores (WAS ) [7] for combining scores from
different algorithms and is available in Ensembl’s Variant Effect
Predictor. Another combined model (known as CAROL) is based
on a weighted Z method of each individual score [8]. As hard
filtering is usually done before prediction methods are applied in
exome sequencing studies of Mendelian diseases [1,3], it is
important for prediction methods to distinguish pathogenic
nsSNVs from other rare variants. However, a number of
individual methods (including PolyPhen2 [9]) and both CONDEL
and CAROL only use common variants as negative controls for
assessing their predictive performance and determining their
optimal cut-offs for variant classification. Since rare and common
variants in the human genome have clearly distinct properties
[10], we argue that such benchmarking may not be appropriate to
exome sequencing studies.
In this paper, we first proposed the use of a logit model to
combine prediction scores from multiple methods and tailored it to
compute an unbiased estimate of the probability of a rare nsSNV
being pathogenic. Then, we assessed the performance of five
popular prediction methods (HumVar-trained PolyPhen2, SIFT
[11], LRT [12], MutationTaster [13], PhyloP [14]) and two
combined models (CONDEL and logit) in distinguishing patho-
genic nsSNVs from other rare variants. As a comparison, we also
examined the predictive powers of these methods in discriminating
between pathogenic and common nsSNVs using HumVar [9] as a
benchmark dataset. In addition, we saw if these prediction methods
could discriminate between autosomal dominant and autosomal
recessive disease mutations. Furthermore, we estimated the
proportion of pathogenic rare variants and total load of pathogenic
derived alleles an individual carries using high coverage exome
sequencing data from the HapMap project. Finally, we applied the
logit prediction model to three in-house exome sequencing subjects
to demonstrate its performance in real data.
For clarity, throughout this paper, being deleterious means that
an nsSNV is under purifying selection; being damaging means that
an nsSNV leads to a loss of protein function; and being pathogenic
means that an nsSNV has an effect on a Mendelian disease
phenotype.
Results
Performance of prediction methods in distinguishing
pathogenic nsSNVs from other rare nsSNVs
Figure 1 shows the Receiver Operating Characteristic (ROC)
and Precision-Recall (PR) curves of the five individual methods
(HumVar-trained PolyPhen2 [10], SIFT [11], LRT [12],
MutationTaster [13], PhyloP [14], see a description of each
method in Table S1) and two combined methods (the proposed
logit model and CONDEL [7], based on the scores from all five
individual methods) evaluated on ExoVar (a dataset composed of
pathogenic nsSNVs and nearly non-pathogenic rare nsSNVs)
using a 10-fold cross-validation (see Materials and Methods). The
logit model clearly outperforms all other methods in terms of the
Areas Under the Curve (AUCs) of ROC and PR. The averaged
maximal Matthews correlation coefficient (MCC) [15] of the logit
model and CONDEL in a 10-fold cross-validation are 0.615 and
0.558 respectively. Contrary to our intuition, we found that the
predictive power of CONDEL combining five individual methods
is slightly inferior to that of one individual method (i.e.,
MutationTaster) in terms of ROC AUC, although it is better
than those of all five individual methods in terms of PR AUC.
Among the five individual prediction methods, MutationTaster,
which considered multiple resources such as evolutionary conser-
vation, splice-site changes and loss of protein features, outperforms
the others in classifying pathogenic variants in this dataset. In
contrast, PhyloP, which considers only evolutionary conservation,
has the smallest AUCs, indicating that information other than
evolutionary conservation is also important in classifying patho-
genic nsSNVs. Nonetheless, these results suggest that the logit
model is able to take advantage of the complementarily between
predictions of different individual methods (which are only weakly
and moderately correlated, see Figure S1) to achieve a better
prediction power.
In addition, we investigated whether combining a subset of the
five individual methods in the logit model has similar predictive
power compared to combining all five methods using the same
validation procedure. Interestingly, we found that some reduced
models have similar or slightly better predictive power than the
full model (Figure 2 and Table S2). Among all possible
combinations, a logit model using the scores from SIFT,
Polyphen2 and MutationTaster performs the best, in terms of
ROC AUC and that using the scores from SIFT and
MutationTaster only has similar performance to the full model,
in terms of PR AUC (so later, we will use this model in estimating
the proportion of pathogenic rare nsSNVs and the total load of
pathogenic derived alleles per individual as it requires non-
missing scores for two methods only). In contrast, combining
PhyloP and LRT, which do not incorporate any protein specific
features for prediction, has the worst performance among all
possible combinations.
Performance of prediction methods in distinguishing
pathogenic nsSNVs from common nsSNVs
We also examined the predictive powers of the methods in
discriminating between pathogenic and common nsSNVs evalu-
ated on HumVar (a popular benchmark dataset composed of
pathogenic and common nsSNVs) using a 10-fold cross-validation.
Of note, the HumVar dataset was also used by PolyPhen2 and
CONDEL to benchmark their prediction models for pathogenic
nsSNVs. Figure 3 shows the ROC and PR curves. All combined
models outperform the individual methods in terms of ROC and
PR AUC, but the predictive power of a logit model is still better
than that of CONDEL. The averaged maximal MCC of the logit
Author Summary
Sequencing the coding regions of the human genome is
becoming a standard approach in identifying causal genes
for human Mendelian diseases. Researchers often rely on
multiple functional prediction methods/tools to separate
the candidate causal mutation(s) from other rare muta-
tions in these studies. In this paper, we propose the use of
a statistical model to combine prediction scores from
multiple methods and to estimate the chance of a rare
mutation being Mendelian disease-causing (or pathogen-
ic). We found that our model using all or some individual
prediction methods consistently outperforms other pre-
diction methods examined and could exclude more than
55% of rare non-pathogenic mutations in an individual
genome. Unfortunately, no method was able to discrim-
inate between autosomal dominant and autosomal reces-
sive disease mutations. In addition, based on the predic-
tions of our model, we estimated that a person can carry
,22 pathogenic derived alleles at least, which if present at
the same position in the genome may lead to Mendelian
diseases.
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Figure 1. ROC and PR curves of prediction methods evaluated on the ExoVar dataset using a 10-fold cross-validation. (a) ROC and (b)
PR. AUC is shown next to the name of each method.
doi:10.1371/journal.pgen.1003143.g001
Figure 2. ROC and PR curves of combining a subset of the five individual methods in a logit model evaluated on the ExoVar dataset
using a 10-fold cross-validation. (a) ROC and (b) PR. AUC is shown next to the name of each method.
doi:10.1371/journal.pgen.1003143.g002
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model and CONDEL in a 10-fold cross-validation are 0.664 and
0.616 respectively. More importantly, all methods have less
predictive power, in terms of ROC and PR AUC, in distinguishing
pathogenic nsSNVs from other rare nsSNVs than from common
nsSNVs.
Performance of prediction methods in discriminating
between autosomal dominant and autosomal recessive
disease nsSNVs
Figure 4 shows the ROC and PR curves of the methods
evaluated on a dataset composed of autosomal dominant and
autosomal recessive disease-causing nsSNVs, DomRec, using a 3-
fold cross-validation. Although there is a significant difference in
prediction scores between the two classess of disease mutations
(with the largest difference observed in PhyloP, Mann-Whitney U
test p-value = 4.5661024) (see Table 1), no method can confi-
dently discriminate between the two classes of mutations (ROC
and PR AUCs of all methods <0.5, i.e., random prediction)
(Figure 4). These results suggest that there is not enough
information to characterize autosomal dominant and recessive
disease mutations in these prediction tools.
Estimation of the proportion of pathogenic rare nsSNVs
and the total load of pathogenic derived alleles per
individual
To calculate an unbiased (posterior) probability of a rare nsSNV
being pathogenic in a logit model (See Materials and Methods), we
need to estimate the prior probability, i.e., the proportion of
pathogenic rare nsSNVs in an individual genome. Therefore, we
downloaded the high coverage exome sequencing data of 8
HapMap individuals [1] and estimated the proportion of patho-
genic rare nsSNVs in each individual to get an estimate of the true
prior with adjustment for sensitivity and specificity of the prediction
(See Materials and Methods). Also, we obtained the total load of
pathogenic derived alleles (See Materials and Methods). We used a
reduced logit model that combines the scores from SIFT and
MutationTaster (with 80.2% averaged sensitivity and 82.8%
averaged specificity ) since it has similar performance to the full
model (in terms of PR AUC) and allows nsSNV with missing scores
for any other three methods to be used. The proportion of predicted
pathogenic rare nsSNVs ranged from 17% to 24% at individual
genomes. After the adjustment of sensitivity and specificity, the true
proportion of rare nsSNVs being pathogenic per individual genome
is estimated to be around 0.6–12.2%, with a mean of 5%.
Consequently, the total load of pathogenic derived alleles per
individual genome varies from 3 to 51, with a mean of 22 (Table 2).
Based on the estimated average load of pathogenic derived alleles
per individual (which is around 22 at least), we calculated the
expected load of homozygous pathogenic variants in an offspring
from consanguineous mating. Given the theoretical inbreeding
coefficient (F) of a child of a consanguineous union [16], the
corresponding number of homozygous pathogenic variants in the
child equals F N /2, where N is the total load of pathogenic derived
alleles in each common ancestor of the consanguineous couple
(Table 3). For example, brother–sister marriages, which constitute
20–30% of all marriages in Roman Egypt [17], would produce
offspring homozygous for the pathogenic derived alleles at 3 loci.
The offspring of first cousins with no family history of Mendelian
diseases would theoretically have 1.4 homozygous pathogenic
variants. However, in reality, there is a large variability in the
values of F for the children of a given relationship. The offspring of
first cousins can have a value of F as little as 3% or as much as 12%
[18], which corresponds to 0.3–1.3 homozygous pathogenic
variants in an individual genome. Therefore, for counseling
purposes, it would be important for genetic counselors to obtain
the actual proportion of genome that the consanguineous couple
shares by descent from common ancestors, say by genome-wide
genotyping using commercial arrays, when assessing the risk to the
offspring of a couple seeking information.
Figure 3. ROC and PR curves of prediction methods evaluated on the HumVar dataset using a 10-fold cross-validation. (a) ROC and
(b) PR. AUC is shown next to the name of each method.
doi:10.1371/journal.pgen.1003143.g003
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Relationship between prior and posterior probabilities of
a rare nsSNV being pathogenic
We found that, on average, around 5% of rare nsSNVs an
individual carries are pathogenic (i.e., the prior probability of a
rare nsSNV being pathogenic <5%), but this does not mean that
every rare nsSNV has the same (posterior) probability of being
pathogenic given the scores from individual prediction methods.
Figure 5 illustrates how both prior probability and prediction
scores determine the posterior probability of a rare nsSNV being
pathogenic. When the prior is large (.0.9), moderate prediction
scores (,0.6) can already lead to a posterior as large as 0.8. But
when the prior is small (,0), only a small posterior is obtained,
regardless of the prediction scores. Within our estimated range of
the prior, the posteriors range from 6.861024 to 0.20 when the
prediction scores are increased from 0 to 1. So when all prediction
scores of an nsSNV reach their maximal values of 1, the
probability that the variant is pathogenic is only around 20%,
indicating that a logit model alone still cannot declare a variant as
pathogenic even with the strong supports from several individual
methods. So additional information (like regions shared among
multiple affected family members) is needed to confidently isolate
the causal variant(s) [3]. In contrast, when all prediction scores of
an nsSNV are close to their minimal values of 0, such probability is
close to 0, indicating that a logit model is confident to declare a
variant as non-pathogenic even with no or little support from
individual prediction methods.
Application of prediction methods to exome-sequencing
studies
We applied the ExoVar-trained logit model using SIFT,
PolyPhen2 and MutationTaster to prioritize nsSNVs in 3
Mendelian-disease patients with in-house exome sequencing data.
Table 4 shows the numbers and percentages of nsSNVs removed
by the hard-filtering approach and functional prediction using the
logit model in these patients. Although hard-filtering (MAF.1%
in dbSNP, HapMap and 1000 Genomes) can exclude ,7,000
Figure 4. ROC and PR curves of prediction methods evaluated on the DomRec dataset using a 3-fold cross-validation. (a) ROC and (b)
PR. AUC is shown next to the name of each method.
doi:10.1371/journal.pgen.1003143.g004
Table 1. Mann–Whitney U test p values for the difference in prediction scores between autosomal dominant and autosomal
recessive disease-causing mutations.
Mean scores
Prediction score Autosomal dominant Autosomal recessive Mann-Whitney U test p-value
PhyloP 0.968 0.929 4.5661024
SIFT 0.947 0.930 1.4061023
PolyPhen2 0.808 0.784 0.018
LRT 0.985 0.962 1.8061023
MutationTaster 0.864 0.842 7.2061023
doi:10.1371/journal.pgen.1003143.t001
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(more than 80% of) nsSNVs, there are still ,1,000 variants left for
examination in each patient. Prediction using different logit
models can further exclude more than 500 (55% of) nsSNVs. Of
note, the causal mutations in these patients (i.e., c.1528G.C of
TGM6 for spinocerebellar ataxia patients [19] in patients 1 and 2
as well as compound heterozygosity for IL10RA mutations:
c.251C.T and c.301C.T [20] in patient 3 with neonatal onset
Crohn’s disease) were all predicted to be pathogenic by the logit
model.
Discussion
In this paper, we propose to use a logit model to combine
multiple prediction methods to increase the performance in
predicting pathogenic nsSNVs and to compute an unbiased
(posterior) probability of an nsSNV being pathogenic in exome
sequencing after hard-filtering. Also, we examine the predictive
power of five popular prediction methods (PolyPhen2, SIFT,
LRT, MutationTaster, PhyloP) and two combined models
(CONDEL and logit) in discriminating between pathogenic
nsSNVs and other rare nsSNVs (which is strictly relevant to
exome sequencing studies). Contrary to our intuition, we found
that the combined approach CONDEL is not necessarily better
than individual methods, as demonstrated by its lower ROC AUC
compared to that of MutationTaster. However, the logit model
using multiple individual methods consistently outperforms other
methods examined and the model combining SIFT and
MutationTaster has comparable or even slightly better perfor-
mance than that combining all of the five individual methods.
Unfortunately, no method is able to discriminate between
autosomal dominant and autosomal recessive disease mutations.
Finally, based on the predictions of the logit model, we estimate
that an individual has around 5% of rare nsSNVs being
pathogenic and carries at least ,22 pathogenic derived alleles,
which if made homozygous by consanguineous marriages may
lead to recessive diseases.
We found that prediction methods are less powerful in
predicting pathogenic variants from other rare variants than from
common variants. This is consistent with the fact that most rare
alleles (no matter whether they are pathogenic or not) of nsSNVs
are subject to strong purifying selection and therefore have similar
structural and functional properties, whereas common nsSNVs (in
which the minor alleles are also found at high frequency in
populations) are subject to weak purifying selection and so have
nearly different properties compared to rare nsSNVs. Thus, as
expected, it is more difficult to separate pathogenic mutations from
other rare nsSNVs than from common nsSNVs using prediction
methods.
There is a significant difference in PhyloP conservation scores
between dominant and recessive disease mutations. This may be
Table 2. The proportion of pathogenic rare nsSNVs and total load of pathogenic derived alleles in 8 HapMap subjects with high
coverage sequencing data.
Population Individual
Number of rare
nsSNVs useda
% of rare variants
predicted to be pathogenic
% of rare nsSNVs
truly pathogenic
Total load of pathogenic
derived alleles (95% CI)b
Caucasian NA12156 384 20.3 5.5 21 (5, 36)
NA12878 426 24.4 12.0 51 (33, 68)
Japanese NA18956 356 19.1 3.6 13 (0, 26)
Chinese NA18555 424 21.2 6.9 29 (12, 46)
African NA18517 660 17.1 0.4 3 (0, 28)
NA18507 623 20.9 6.4 40 (14, 64)
NA19129 629 17.5 1.0 6 (0, 31)
NA19240 688 18.3 2.3 16 (0, 42)
aThe nsSNVs with missing scores at SIFT and/or MutationTaster were not used in the estimation.
bthe 95% confidence interval was derived empirically from randomly repeating 10-fold cross-validation 200 times.
doi:10.1371/journal.pgen.1003143.t002
Table 3. Theoretical inbreeding coefficient (F) and corresponding number of homozygous pathogenic variants in the children of
various relationships, given that on average each individual carries 22 pathogenic derived alleles.
Relationship Inbreeding coefficient, F
Expected number of homozygous pathogenic variants
in children
Siblings 1/4 2.8
Half siblings 1/8 1.4
Uncle-niece, aunt-nephew 1/8 1.4
First cousins 1/16 0.7
First cousins once removed 1/32 0.3
Second cousins 1/64 0.2
Double first cousins 1/8 1.4
Double second cousins 1/32 0.3
doi:10.1371/journal.pgen.1003143.t003
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because dominant disease genes are more conserved than recessive
disease genes which can be ‘‘hidden’’ from purifying selection
while heterozygous [21]. However, none of the prediction
methods we examined, which mainly use the genomic features
at variant level, are able to distinguish autosomal dominant
mutations from autosomal recessive disease-causing mutations.
Presumably, the genomic features at gene level may help
distinguish them. Some studies have analyzed the difference in
Figure 5. The relationship between prior and posterior probabilities of a rare nsSNV being pathogenic, given the prediction scores
from SIFT, PolyPhen2, and MutationTaster. The white dashed lines indicate the estimated range of the prior (5%). We assume that there is no
difference in prediction scores from the three methods for the same variant. The a, bSIFT, bPolyphen2 and bMutationTaster in a selected sample evaluated in
the ExoVar dataset are used in the calculation of posteriors (See Eq. 2 and 3 in Materials and Methods) and take the values of 23.53, 1.64, 1.48, and
2.47 respectively. The prior and posterior are equivalent to the quantity Pdisease in an individual genome in Eq. 3 and P(Y=1|X) in Eq. 2 respectively.
doi:10.1371/journal.pgen.1003143.g005
Table 4. The numbers and proportion of nsSNVs removed by hard-filtering and functional prediction by the logit model in 3
Mendelian-disease patients with in-house exome sequencing data.
Patient 1a Patient 2a Patient 3b
Missense, stop-loss and stop-gain variants 8,383 8,563 7,969
MAF.1% 27,398 (288.3%) 27,552(288.2%) 26,751(284.7%)
= 985 = 1,011 = 1,218
Predicted to be non-pathogenic 2569 (257.8%) 2583 (257.7%) 2702 (257.6%)
= 416c = 428c = 516c
aRelated cases with autosomal dominant spinocerebellar ataxia.
bCase with neonatal-onset Crohn’s disease.
cnsSNVs in which prediction is unavailable due to missing scores.
doi:10.1371/journal.pgen.1003143.t004
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functional classification of the two classes of disease mutations and
found that mutations in genes coding for enzymes and transporters
are most likely to cause recessive diseases, whereas mutations in
transcription regulators, structural molecules, nucleic acid binding
genes and signal transducers have a higher chance to cause
dominant diseases [22,23]. Also, genes involved in recessive
diseases have less conserved paralogs than dominant disease genes
[21,23], as recessive diseases are often caused by loss-of-function
mutations [22,24] (which create a defective protein product with
little or no biologic activity, and/or interfere with the normal
expression of the gene). If a close paralog of a recessive disease
gene is present, the paralog is likely to compensate for the loss of
function due to a mutated recessive disease gene and so the disease
is not observed [25]. On the contrary, dominant diseases are
usually caused by gain-of-function mutations (which confer a new
activity on the gene product, or lead to its inappropriate spatial
and temporal expression) and so the presence of wild-type proteins
encoded by functionally similar paralogs may not suppress the new
functions acquired by the mutant proteins [23].
We found that the correlations among the scores from several
complementary prediction methods are mostly weak to moderate
(see Figure S1). This can occur for two possible reasons. First, the
set of species used by one method for measuring conservation may
be significantly different from those used by another, and thus this
may lead to a big difference between the prediction scores
calculated by the different methods for the same site. Second, the
set of perfectly conserved sites used for training by one method
may also be different from the ones used by others due to the
variation in sequence alignments adopted by each method.
Nevertheless, to our knowledge, MutationTaster uses the largest
amount of resources for training and this may explain its excellent
predictive performance among the five individual methods
examined. But some redundancy among prediction scores from
multiple methods also explains why combining a subset of the five
individual methods (i.e., PolyPhen2, SIFT, and MutationTaster)
has similar predictive performance to combine all five individual
methods in a logit model.
We note that our estimates of the number of pathogenic alleles
per individual from the human genome data are higher than
those from the data on consanguineous marriages (which suggest
a much smaller number, usually less than 10 [26–30]). But
comparison of our estimates with those from inbreeding studies is
difficult since we use totally different method and data. A similar
situation has also occurred in quantifying the number of lethal
equivalents per individual, in which inbreeding studies suggest
that each individual carries 2-6 lethal equivalents [31,32] whereas
Kondrashov [33] found the number could be as high as 100.
Anyway, estimation from inbreeding studies typically relies on an
implicit assumption that all recessive alleles are completely
penetrant and expressive, but examples that violate this
assumption have recently been found. For example, the presence
of a dominant modifier DFNM1 leads to normal hearing in an
individual homozygous for the DFNB26 mutation [34]; high
expression of actin-binding protein plastin 3 (PLS3) protects
individuals carrying homozygous SMN1 deletions from develop-
ing spinal muscular atrophy (SMA) [35]; and among the two
siblings affected by autosomal recessive polycystic kidney disease
(ARPCKD), one died at 18 hr but the other still had no symptom
when presented at 16 [36]. So the numbers from inbreeding
studies are likely to be an underestimate. However, mapping
errors may also inflate our estimates. For example, it was found
that sequencing variants in the inactive gene copy of CDC27
gene (i.e., pseudogene) were wrongly mapped to the active gene
copy of CDC27 [37] and we observed that the active gene copy
of CDC27 had as many as 11 nsSNVs at 2 out of 8 HapMap
subjects examined. It is likely that some of these nsSNVs actually
came from CDC27 pseudogene(s) and that can therefore inflate
our estimates. But missing scores at sequencing variants could, on
the other hand, deflate our estimates. Around 13–17% of rare
nsSNVs in an individual have missing scores at SIFT and/or
MutationTaster and so pathogenic alleles in these variants cannot
be counted.
We also observed a marked variability in our estimates of the
number of pathogenic alleles per individual. The statistical
fluctuation of specificity is the major reason for the large
variability. As shown in Table 2, a standard error of 1.3% in
specificity can already lead to a standard error of 1.9% in the
estimated proportion of pathogenic rare variants and finally results
in a standard error of ,10–15 in the estimated total load of
pathogenic rare variants.
We showed that, after MAF filtering, the prior (i.e., the
proportion of variants left being pathogenic) is low (which is
around 5% and leads to a posterior probability of ,20% at
most) and so it is still difficult for prediction methods to pinpoint
the pathogenic mutation(s) in exome sequencing studies of
Mendelian diseases. One way to increase the prior is to use
additional information, including genomic regions shared by
multiple affected family members and known biological path-
ways, to reduce the number of candidate pathogenic variants
and therefore we have implemented these functions in
KGGSeq. We also found that even low prediction scores can
lead to a posterior that can help exclude non-pathogenic
variants. Using the exome sequencing data of three patients with
Mendelian diseases, we observed that a logit model could
exclude more than 55% of rare nsSNVs. Moreover, these
posterior probabilities can be used as weights of the nsSNVs for
other analyses.
Materials and Methods
Benchmark datasets
ExoVar. This dataset is composed of 5,340 alleles with known
effects on the molecular function causing human Mendelian
diseases from the UniProt database, which are treated as positive
control variants, and 4,752 rare (alternative/derived allele
frequency ,1%) nsSNVs with at least one homozygous genotype
for the alternative/derived allele in the 1000 Genomes Project,
which are treated as negative control variants. This dataset can be
downloaded from our KGGSeq website (see Data Access). It is
used for evaluating the performance of prediction methods in
distinguishing pathogenic nsSNVs from other rare variants. This
benchmark dataset can be downloaded at http://statgenpro.
psychiatry.hku.hk/limx/kggseq/download/ExoVar.xls.
HumVar. This dataset was prepared by the PolyPhen2 team
for benchmarking their program and is available online (see Data
Access). It consists of 22,196 human disease-causing or loss of
activity/function mutations (except cancer mutations) present in
the UniProtKB database, which are treated as positive control
variants, together with 21,151 common (MAF.1%) nsSNVs with
no reported disease association, which are treated as negative
control variants. Of note, HumVar was used by PolyPhen2 and
CONDEL for benchmarking models used for predicting patho-
genic nsSNVs.
DomRec. To examine the performance of predictive models
in discriminating between autosomal dominant and autosomal
recessive disease mutations, we retrieved from Galaxy [38,39] 253
nsSNVs causing only autosomal dominant diseases and 389
nsSNVs causing only autosomal recessive diseases.
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Functional prediction scores
We obtained, from dbNSFP database v2.0 [40], the prediction
scores from four prediction algorithms (SIFT, HumVar-trained
Polyphen2, LRT and MutationTaster) and a conservation score
(PhyloP) for each nsSNV in the human genome (hg19). Some
methods (e.g. MutationTaster) reported predictions for alternative
(or non-reference) alleles while some (e.g. PolyPhen2) conducted
predictions for derived (or non-ancestral) alleles. To avoid
inconsistency in predictions, we removed variants whose alterna-
tive alleles are not derived alleles. We also downloaded the
CONDEL perl script from the authors’ website (see Data Access)
and used it to compute a CONDEL WAS score for each nsSNV
based on the scores from all five individual methods. For all
methods, the scores were standardized to range from 0 to 1 and, in
general, the larger the score, the higher the probability of causing
diseases.
Exome sequencing datasets
HapMap. We downloaded the protein coding SNVs of 8
HapMap individuals with high coverage exome sequencing data
[1] (see Data Access). They are NA12156 and NA12878from
Caucasians, NA18956 from Japanese (Asian), NA18555 from
Chinese (Asian), as well as NA18517, NA18507, NA19129 and
NA19240 from Africans.
In-house. Two samples came from an autosomal dominant
spinocerebellar ataxia pedigree [19] and another from a neonatal-
onset Crohn’s disease pedigree [20]. They were collected in Hong
Kong with Institutional Review Board approval and were
sequenced by the Illumina Genome Analyzer II platform at
deCODE Genetics. The paired-end 76-bp short reads from
Illumina Genome Analyzer II were aligned and mapped onto the
UCSC human reference genome (hg18), by Burrows-Wheeler
Aligner [41]. Duplicated reads were marked by Picard (see Data
Access). The Genome analysis toolkit (GATK) [42] was then used
to recalibrate the alignments and to call SNVs (by UnifiedGen-
otyper).
Logit model for combining individual prediction tools
Given a vector, X, of prediction scores from multiple prediction
methods for a particular nsSNV, the (posterior) probability that
the nsSNV is pathogenic (Y=1) is given by:
P(Y~1DX )~1
½1ze{(azbX ) ð1Þ
where a and b are, respectively, the constant and vector of
coefficients of X from logistic regression on a population (or
random sample) of pathogenic (positive control) and other
(negative control) variants. However, when the sample (bench-
mark dataset) is selected, the probability in Eq. 1 would be biased.
An unbiased estimate of (posterior) probability can be obtained by
(see Text S1):
P(Y~1DX )~1
½1zR  e{(azbX ) ð2Þ
where R is the odds of a variant being pathogenic in the selected
sample divided by that in the population (i.e., an individual
genome), i.e.,
R~
Pdisease in a selected sample
1{Pdisease in a selected sample

Pdisease in an individual genome
1{Pdisease in an individual genome
ð3Þ
where Pdisease denotes the proportion of pathogenic nsSNVs. Note
that the value of R is the same for all variants and affects only the
probability calculated, but not variant classification. Also, in our
case, Pdisease in a selected sample is simply the proportion of
positive control variants among all variants included in the
benchmark dataset. We will demonstrate how Pdisease in an
individual genome can be obtained in the section below.
Assessment of predictive power
We evaluated the performance of five individual methods
(SIFT, HumVar-trained Polyphen2, LRT, MutationTaster, and
PhyloP) and two combined methods (CONDEL WAS and logit) in
discriminating between
1. pathogenic nsSNVs and other rare variants using a 10-fold
cross-validation on the ExoVar dataset;
2. pathogenic nsSNVs and common variants using a 10-fold
cross-validation on the HumVar dataset, and;
3. autosomal dominant and autosomal recessive disease-causing
nsSNVs using a 3-fold cross-validation on the DomRec dataset.
The parameters a and b in the logit model, as well as the
complementary cumulative distributions and optimal cutoffs (that
maximizes MCC) for each individual prediction method required
by CONDEL were obtained from the training dataset in each fold
in a K-fold cross-validation. When we validated the trained models
in a test dataset, the probability cutoff was increased from 0 to 1
and the corresponding true positive prediction rate (sensitivity) and
true negative prediction rate (specificity) of different prediction
methods were recorded. We built the ROC and PR curves and
reported the MCC [15], ROC AUC and PR AUC of each
method evaluated on each benchmark dataset. The program
AUCCalculator [43] was used to calculate the AUCs. The
sensitivities and specificities from K folds in a K-fold cross-
validation were averaged for ROC and PR curve plotting. For the
logit model, the quantity R in Eq. 3 is assumed to be 1 as this
affects only the biasness of the probability calculated but not
classification. Furthermore, we evaluated the effect of using a
subset instead of all five individual methods in the logit model on
the power in distinguishing pathogenic nsSNVs from other rare
variants using a 10-fold cross-validation on the ExoVar dataset.
Estimation of the proportion of pathogenic rare nsSNVs
and the total load of pathogenic derived alleles per
individual
To obtain an estimated range of Pdisease, i.e., the proportion of
pathogenic rare nsSNVs in an individual genome, in Eq. 3, we
need to get an estimated range of P*disease, i.e., the proportion of
predicted pathogenic rare nsSNVs in an individual genome. To
estimate P*disease, we downloaded the high coverage exome
sequencing data of 8 HapMap individuals and removed common
nsSNVs annotated in dbSNP and 1000 Genomes using KGGSeq.
Then, prediction was done in these filtered datasets using a logit
model (with a cutoff that maximizes the MCC evaluated on the
ExoVar dataset) to obtain P*disease for each of the individuals.
Given the specificity and sensitivity of the prediction model used,
we have
Pdisease in an individual genome~
½Pdisease in an individual genome{(1{specificity)
.
½sensitivity{(1{specificity)
ð4Þ
Since the number of homozygous genotypes for the derived allele
in an individual is small compared to that of heterozygous
genotypes, result from the prediction and estimation on all
genotypes is similar to that on heterozygous genotypes only. So, for
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simplicity, we reported the latter results. That also simplifies our
calculation of the total load of pathogenic derived alleles in each
individual presented as the value just equals the number of
pathogenic rare variants.
To quantify the variability in the estimates of the total load of
pathogenic derived alleles per individual, we randomly repeated
the 10-fold cross validation 200 times. Each round of 10-fold cross
validation generates a pair of averaged sensitivity and specificity
values and this pair of values is then used to calculate Pdisease
according to equation (4) and the total load of pathogenic derived
alleles. We obtained the 95% confidence interval (CI) of the total
load of pathogenic derived alleles by taking the 2.5% and 97.5%
quantiles in the distribution of 200 such estimates.
Implementation
We implemented the logit model as one of important functions
in our KGGseq software package, which was designed to conduct
knowledge-based downstream analyses in sequencing studies.
KGGSeq also gives a posterior probability of being pathogenic
for each nsSNV by combining the five individual prediction scores
available in the dbNSFP database v2.0 [40]. These features should
facilitate the ranking and/or filtering of nsSNVs in exome
sequencing studies of Mendelian diseases.
Application to exome sequencing data
We applied the logit model to the in-house exome sequencing
data of three patients. KGGSeq was used to exclude variants and
genotypes with low quality (read coverage#46, Phred-scaled base
sequencing quality#50, and Phred-scaled genotype calling quality
score #20), map variants onto the reference genome (hg18),
extract nsSNVs as well as remove known common nsSNVs
(annotated in dbSNP and 1000 Genomes). Finally, for each of the
remaining rare nsSNVs, KGGSeq assigned a logit prediction
score, a posterior probability of being pathogenic and decided
whether it is pathogenic or not using a cutoff that maximizes the
MCC in ExoVar dataset.
Data access
The URLs for data presented herein are as follows:
KGGseq software tool, http://statgenpro.psychiatry.hku.hk/
kggseq/
ExoVar dataset, http://statgenpro.psychiatry.hku.hk/limx/
kggseq/download/ExoVar.xls
dbNSFP, http://sites.google.com/site/jpopgen/dbNSFP
Galaxy, http://main.g2.bx.psu.edu/library
Polyphen2HumVar dataset, http://www.nature.com/nmeth/
journal/v7/n4/suppinfo/nmeth0410-248_S1.html
Online Mendelian Inheritance in Man, http://www.ncbi.nlm.
nih.gov/Omim
1000 Genomes Project data, http://www.sph.umich.edu/csg/
abecasis/MACH/download/
Polyphen-2 website, http://genetics.bwh.harvard.edu/pph2/
UniProt website, http://www.uniprot.org/
Picard website, http://picard.sourceforge.net/;
High coverage exome sequencing data of 8 HapMap individ-
uals, http://krishna.gs.washington.edu/12_exomes/;
CONDEL, http://bg.upf.edu/condel/home
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from the five individual algorithms (SIFT, HumVar-trained
Polyphen2, LRT, MutationTaster, and PhyloP) in HumVar’s a)
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